Novel Erythromycin Derivatives with Aryl Groups Tethered to the C-6 Position Are Potent Protein Synthesis Inhibitors and Active against Multidrug-Resistant Respiratory Pathogens-Reference-Cited by-同舟云学术

Novel Erythromycin Derivatives with Aryl Groups Tethered to the C-6 Position Are Potent Protein Synthesis Inhibitors and Active against Multidrug-Resistant Respiratory Pathogens

Published:2001-10-18 Issue:24 Volume:44 Page:4137-4156
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Ma Zhenkun¹,Clark Richard F.¹,Brazzale Antony¹,Wang Sanyi¹,Rupp Michael J.¹,Li Leping¹,Griesgraber George¹,Zhang Suoming¹,Yong Hong¹,Phan Ly Tam¹,Nemoto Peter A.¹,Chu Daniel T. W.¹,Plattner Jacob J.¹,Zhang Xiaolin¹,Zhong Ping¹,Cao Zhensheng¹,Nilius Angela M.¹,Shortridge Virginia D.¹,Flamm Robert¹,Mitten Michael¹,Meulbroek Jon¹,Ewing Patty¹,Alder Jeff¹,Or Yat Sun¹

Affiliation:

1. Infectious Disease Research, Abbott Laboratories, 200 Abbott Park Road, Abbott Park, Illinois 60064-3537

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm0102349

Reference61 articles.

1. Survey of Susceptibilities of Streptococcus pneumoniae , Haemophilus influenzae , and Moraxella catarrhalis Isolates to 26 Antimicrobial Agents: a Prospective U.S. Study

2. Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in North America

3. New faces of an old pathogen: emergence and spread of multidrug-resistant Streptococcus pneumoniae

4. Antimicrobial Resistance withStreptococcus pneumoniaein the United States, 1997–98

Cited by 124 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rational utilization of 1,2,3-triazole scaffold in anti-MRSA drug development: Design strategies, structural insights and pharmacological outcomes;Journal of Molecular Structure;2024-01

2. WCK 4873 (INN: Nafithromycin): Structure–activity relationship (SAR) identifying a novel lactone ketolide with activity against Streptococcus pneumoniae (SPN) and Streptococcus pyogenes (SPY);Results in Chemistry;2023-01

3. Design, synthesis and structure–activity relationships of novel N11-, C12- and C13-substituted 15-membered homo-aza-clarithromycin derivatives against various resistant bacteria;Bioorganic Chemistry;2021-08

4. Design, synthesis and antibacterial evaluation of novel C-11, C-9 or C-2′-substituted 3-O-descladinosyl-3-ketoclarithromycin derivatives;Bioorganic & Medicinal Chemistry Letters;2021-07

5. The impact and fate of clarithromycin in anaerobic digestion of waste activated sludge for biogas production;Environmental Research;2021-04